*Synera* pain patch

Synera Approved To Soothe Discomfort After Needle Sticks

Synera™ (lidocaine 70 mg and tetracaine 70 mg) topical patch

The Synera anesthetic patch was approved by the Food and Drug Administration in June 2005 for use in relieving pain after intravenous infusions, blood draws and dermatology procedures and will now be available by prescription.

Synera™ is indicated for use on intact skin to provide local dermal analgesia for superficial venous access and superficial dermatological procedures such as excision, electrodessication and shave biopsy of skin lesions.

The Synera heating component generates a mild warming that is intended to enhance the delivery of the local anesthetic. Synera begins to heat once the patch is removed from the pouch and is exposed to oxygen in the air. Although the patch may increase skin temperature by up to approximately 5ºC, maximum skin temperature will not exceed 40ºC.

Venipuncture or Intravenous Cannulation:
Prior to venipuncture or intravenous cannulation, apply Synera to intact
skin for 20-30 minutes.

Superficial Dermatological Procedures:
For superficial dermatological procedures such as superficial excision or shave biopsy, apply Synera to intact skin for 30 minutes prior to the procedure.

FDA/APF